Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (6)
  • 2025 (44)
  • 2024 (32)
  • 2023 (22)
  • 2022 (32)
  • 2021 (57)
  • 2020 (48)
  • 2019 (46)
  • 2018 (73)
  • 2017 (63)
  • 2016 (51)
  • 2015 (41)
  • 2014 (53)
  • 2013 (66)
  • 2012 (16)
  • 2011 (59)

Subject

  • Drug Trafficking (72)
  • Synthetic drugs (34)
  • Prescription Drugs (32)
  • Take Back Day (29)
  • Arrests/Convictions - Major (28)
  • Outreach/Drug Prevention (27)
  • Fake Pills (24)
  • Overdose (23)
  • Fentanyl Awareness (20)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Seizures (Drugs/Property) (16)
  • Guns/Weapons (14)
  • Major Law Enforcement Operation (14)
  • Diversion Division (13)
  • Pharmaceuticals/Pharmacists/Physicians (13)
  • Congressional Affairs (12)
  • One Pill Can Kill (12)
  • Press Conferences (12)
  • Prevention/Education - DEA websites GSAD, JTT etc (9)
  • Red Ribbon (9)
  • Money Laundering (8)
  • Narcoterrorism (7)
  • OCDETF/Task Force (7)
  • International/Foreign Operations (6)
  • Extraditions (4)
  • Fentanyl Free America (4)
  • Guilty Plea (4)
  • HIDTA (4)
  • Intergovernmental Affairs (4)
  • Counterfeit Pills (3)
  • Critical Incident (3)
  • Gangs (3)
  • Other (3)
  • Terrorism (3)
  • Campaigns (2)
  • Scam Calls (2)
  • Task Forces/Task Force Officers (2)
  • Dark Web- Internet Trafficking (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)

Drug Name

  • Fentanyl (74)
  • Methamphetamine (45)
  • Cocaine (35)
  • Heroin (17)
  • Marijuana (Cannabis) (8)
  • Synthetic Opioids (6)
  • Opioids (5)
  • Oxycodone (5)
  • Ketamine (2)
  • Marijuana Concentrates (2)
  • Benzodiazepines (1)
  • Ecstasy/MDMA (1)
  • GHB (1)
  • Psilocybin (1)

Field Division

  • New England (2385)
  • New York (1521)
  • Houston (907)
  • San Francisco (847)
  • Miami (840)
  • Seattle (812)
  • St. Louis (808)
  • Atlanta (777)
  • Chicago (629)
  • Washington, DC (617)
  • New Jersey (493)
  • New Orleans (481)
  • Detroit (361)
  • El Paso (350)
  • Dallas (315)
  • Phoenix (274)
  • San Diego (246)
  • Rocky Mountain (166)
  • Philadelphia (140)
  • Omaha (137)
  • Louisville (81)
  • Caribe (79)
  • Caribe (1)
  • Sede (414)
  • Los Angeles (300)
Clear All Results
709 Results - Showing 271 to 280
PRESS RELEASE

DEA hosts industry association conference as part of continued collaboration on prescription drug abuse

WASHINGTON - DEA Assistant Administrator, Diversion Control Division John Martin recently hosted a collaborative conference in Washington, D.C. with industry leaders representing the prescription drug supply chain in America. The purpose of their dialogue was to discuss ways to minimize pharmaceutical diversion while maintaining legitimate commerce and patient access. “DEA...
PRESS RELEASE

Members of African criminal enterprise charged with large-scale trafficking of rhinoceros horns and elephant ivory and heroin distribution

NEW YORK – DEA Special Operations Division Special Agent in Charge Christopher T. Tersigni, United States Attorney for the Southern District of New York Geoffrey S. Berman and United States Secretary of the Interior David Bernhardt announced that Moazu Kromah, aka “Ayoub,” aka “Ayuba,” aka “Kampala Man;” Amara Cherif, aka...
PRESS RELEASE

DEA and U.S. Attorney in the Western District of Louisiana announce settlement with drug distributor

NEW ORLEANS – Morris & Dickson Company LLC has agreed to pay the United States $22 million in civil penalties to resolve claims that it violated the Controlled Substances Act by failing to report suspicious orders of hydrocodone and oxycodone, announced Drug Enforcement Administration Special Agent in Charge Brad L...
PRESS RELEASE

Major financial sanctions announced against Mexico’s largest drug cartel investigated by DEA Los Angeles

LOS ANGELES – DEA’s Los Angeles Division continues to lead the global investigation into Mexico’s most violent and largest drug cartel, the Cartel de Jalisco Nueva Generacion (CJNG) and it’s leader Nemesio Oseguera-Cervantes, aka "El Mencho." DEA Los Angeles Division indicted El Mencho on federal drug trafficking charges in 2014...
PRESS RELEASE

DEA Los Angeles Special Agent in Charge David J. Downing to retire on May 31

LOS ANGELES – After 24 years of dedicated service to the United States, Special Agent in Charge (SAC) David J. Downing III of the Drug Enforcement Administration’s Los Angeles Division will retire on May 31. “This decision was not an easy one,“ said SAC Downing. “But it’s time.” Mr. Downing...
PRESS RELEASE

Five Estonian residents arrested for conspiring to import carfentanil and fentanyl into the United States

WASHINGTON – Christopher T. Tersigni, Special Agent in Charge of the Special Operations Division of the U.S. Drug Enforcement Administration, and Geoffrey S. Berman, the U.S. Attorney for the Southern District of New York, today announced that Estonian residents Jevgeni Bokov, Viktor Litvintsuk, Amid Magerramov, Nikolai Niftalijev, and Vitali Voronjuk...
PRESS RELEASE

Global investigation of Dark Web drug network leads to arrest of 3 German Nationals

WASHINGTON – After a two-year investigation into one of the world’s largest dark web marketplaces, the DEA and other law enforcement partners today announced the arrests of three German nationals who operated the site, which sold illegal drugs and other goods to over a million customers. The three defendants were...
PRESS RELEASE

DEA’s 17th National Prescription Drug Take Back Day has highest-ever partner participation

WASHINGTON – With enthusiastic participation nationwide, DEA and its law enforcement partners have now collected nearly 12 million pounds of unused or expired prescription medications over the course of 17 successful DEA National Prescription Drug Take Back events. During the 17th semiannual event on April 27, the Take Back initiative...
PRESS RELEASE

Extradition of Pakistani man for attempted heroin importation

NEW YORK – DEA Special Operations Division Special Agent in Charge Christopher T. Tersigni and U.S. Attorney for the Southern District of New York Geoffrey S. Berman announced today the extradition of Muhammad Khalid Khan for attempting to import heroin into the United States and laundering what he believed to...
PRESS RELEASE

DEA and partners hold National Prescription Drug Take Back Day

WASHINGTON – With robust public participation over the course of 16 prior events, the National Prescription Drug Take Back Day Initiative continues to remove ever-higher amounts of opioids and other medicines from the nation’s homes, where they are vulnerable to misuse, theft or abuse by family members and visitors, including...

Paginación

  • Primera página «
  • Anterior
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Current page 28
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster